BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35586951)

  • 1. T-cell-derived Hodgkin lymphoma has motility characteristics intermediate between Hodgkin and anaplastic large cell lymphoma.
    Bein J; Flinner N; Häupl B; Mathur A; Schneider O; Abu-Ayyad M; Hansmann ML; Piel M; Oellerich T; Hartmann S
    J Cell Mol Med; 2022 Jun; 26(12):3495-3505. PubMed ID: 35586951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The histologic, immunohistochemical, and genetic features of classical Hodgkin lymphoma and anaplastic large cell lymphoma with aberrant T-cell/B-cell antigen expression.
    Liang K; Wang J; Wang Y; Zhou Z; Ge S; Mei S; Li H; Jing X; Zhang C
    Hum Pathol; 2019 Feb; 84():309-320. PubMed ID: 30339972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma.
    Eckerle S; Brune V; Döring C; Tiacci E; Bohle V; Sundström C; Kodet R; Paulli M; Falini B; Klapper W; Chaubert AB; Willenbrock K; Metzler D; Bräuninger A; Küppers R; Hansmann ML
    Leukemia; 2009 Nov; 23(11):2129-38. PubMed ID: 19657361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migration Properties Distinguish Tumor Cells of Classical Hodgkin Lymphoma from Anaplastic Large Cell Lymphoma Cells.
    Goncharova O; Flinner N; Bein J; Döring C; Donnadieu E; Rikirsch S; Herling M; Küppers R; Hansmann ML; Hartmann S
    Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31581676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PD-1/PD-L1 Pathway and Its Blockade in Patients with Classic Hodgkin Lymphoma and Non-Hodgkin Large-Cell Lymphomas.
    Xie W; Medeiros LJ; Li S; Yin CC; Khoury JD; Xu J
    Curr Hematol Malig Rep; 2020 Aug; 15(4):372-381. PubMed ID: 32394185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of the t(2;5) (p23; q35) translocation in anaplastic large cell lymphoma (Ki-1) and Hodgkin's disease.
    Yee HT; Ponzoni M; Merson A; Goldstein M; Scarpa A; Chilosi M; Menestrina F; Pittaluga S; de Wolf-Peeters C; Shiota M; Mori S; Frizzera G; Inghirami G
    Blood; 1996 Feb; 87(3):1081-8. PubMed ID: 8562933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AP1-dependent galectin-1 expression delineates classical hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features.
    Rodig SJ; Ouyang J; Juszczynski P; Currie T; Law K; Neuberg DS; Rabinovich GA; Shipp MA; Kutok JL
    Clin Cancer Res; 2008 Jun; 14(11):3338-44. PubMed ID: 18519761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fascin expression in diffuse large B-cell lymphoma, anaplastic large cell lymphoma, and classical Hodgkin lymphoma.
    Bakshi NA; Finn WG; Schnitzer B; Valdez R; Ross CW
    Arch Pathol Lab Med; 2007 May; 131(5):742-7. PubMed ID: 17488159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
    Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
    Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An oncogenic axis of STAT-mediated BATF3 upregulation causing MYC activity in classical Hodgkin lymphoma and anaplastic large cell lymphoma.
    Lollies A; Hartmann S; Schneider M; Bracht T; Weiß AL; Arnolds J; Klein-Hitpass L; Sitek B; Hansmann ML; Küppers R; Weniger MA
    Leukemia; 2018 Jan; 32(1):92-101. PubMed ID: 28659618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brefeldin A exerts differential effects on anaplastic lymphoma kinase positive anaplastic large cell lymphoma and classical Hodgkin lymphoma cell lines.
    Toda T; Watanabe M; Kawato J; Kadin ME; Higashihara M; Kunisada T; Umezawa K; Horie R
    Br J Haematol; 2015 Sep; 170(6):837-46. PubMed ID: 26105086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.
    Stein H; Foss HD; Dürkop H; Marafioti T; Delsol G; Pulford K; Pileri S; Falini B
    Blood; 2000 Dec; 96(12):3681-95. PubMed ID: 11090048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.
    Dirks WG; Zaborski M; Jäger K; Challier C; Shiota M; Quentmeier H; Drexler HG
    Leukemia; 1996 Jan; 10(1):142-9. PubMed ID: 8558920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAX-5 Positivity in Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma: A Case Report and Review of Literature.
    Arun I; Roy P; Arora N; Bhave SJ; Nair R; Chandy M
    Int J Surg Pathol; 2017 Jun; 25(4):333-338. PubMed ID: 28013563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IRF8 as a Novel Marker to Differentiate Between CD30-Positive Large Cell Lymphomas.
    McQuaid DC; Katz SG; Xu ML
    Am J Clin Pathol; 2022 Aug; 158(2):173-176. PubMed ID: 35460405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hodgkin-like anaplastic large cell lymphoma (previously designated in the REAL classification) has same immunophenotypic features to classical Hodgkin lymphoma.
    Tamaru J; Tokuhira M; Nittsu N; Nakamura S; Ichinohasama R; Suzuki R; Mori H; Takagi T; Suzuki T; Itami J; Itoyama S; Mikata A
    Leuk Lymphoma; 2007 Jun; 48(6):1127-38. PubMed ID: 17577776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The c-Jun and JunB transcription factors facilitate the transit of classical Hodgkin lymphoma tumour cells through G
    Zhang J; Wu Z; Savin A; Yang M; Hsu YR; Jantuan E; Bacani JTC; Ingham RJ
    Sci Rep; 2018 Oct; 8(1):16019. PubMed ID: 30375407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of granzyme B sensitizes ALK+ ALCL tumour cells to apoptosis-inducing drugs.
    Pearson JD; Zhang J; Wu Z; Thew KD; Rowe KJ; Bacani JT; Ingham RJ
    Mol Cancer; 2014 Aug; 13():199. PubMed ID: 25168906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma.
    Wurster KD; Hummel F; Richter J; Giefing M; Hartmann S; Hansmann ML; Kreher S; Köchert K; Krappmann D; Klapper W; Hummel M; Wenzel SS; Lenz G; Janz M; Dörken B; Siebert R; Mathas S
    Leukemia; 2017 Mar; 31(3):602-613. PubMed ID: 27538486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas.
    Mathas S; Jöhrens K; Joos S; Lietz A; Hummel F; Janz M; Jundt F; Anagnostopoulos I; Bommert K; Lichter P; Stein H; Scheidereit C; Dörken B
    Blood; 2005 Dec; 106(13):4287-93. PubMed ID: 16123212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.